Charles River Labs (CRL) Pulled Back Due to AI Disruption Fears
Key takeaways
- A copy of the letter is available to download here.
- In its first-quarter 2026 investor letter, Madison Small Cap Fund Strategy highlighted stocks such as Charles River Laboratories International, Inc.
- Madison Small Cap Fund stated the following regarding Charles River Laboratories International, Inc.
Charles River Labs (CRL) Pulled Back Due to AI Disruption Fears Soumya Eswaran Fri, June 12, 2026 at 10:26 PM GMT+7 3 min read ^RUT CRL Madison Small Cap Fund, managed by Madison Funds, released its Q1 2026 investor letter. A copy of the letter is available to download here. The Madison Small Cap Fund (class I) increased by 0.10% in the first quarter, trailing behind the Russell 2000 Index (up 0.89%) and the Russell 2500 Index (up 2.04%). Despite slightly underperforming the benchmark in the quarter, core positions and IT investments showed solid performance. From a style perspective, value stocks outperformed growth, with the Russell 2000 Value Index rising ~4.5% and the Russell 2000 Growth Index falling almost 3%. The outperformance of the value is driven by weakness in speculative names aligning with the Fund’s style and preference for quality, profitable franchises. The Fund believes the market volatility, influenced by AI concerns and geopolitical tensions, presents a potential opportunity for patient investors. Please review the Fund’s top five holdings to gain insights into their key selections for 2026.
In its first-quarter 2026 investor letter, Madison Small Cap Fund Strategy highlighted stocks such as Charles River Laboratories International, Inc. (NYSE:CRL). Charles River Laboratories International, Inc. (NYSE:CRL) is a contract research organization that provides drug discovery, development, and safety testing services to pharmaceutical and biotechnology firms. On June 11, 2026, Charles River Laboratories International, Inc. (NYSE:CRL) closed at $188.06 per share. One-month return of Charles River Laboratories International, Inc. (NYSE:CRL) was 24.67%, and its shares gained 25.83% over the past 52 weeks. Charles River Laboratories International, Inc. (NYSE:CRL) has a market capitalization of $9.06 billion.
Madison Small Cap Fund stated the following regarding Charles River Laboratories International, Inc. (NYSE:CRL) in its Q1 2026 investor letter: